BIOSPECIFICS TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options, 1997

BIOSPECIFICS TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows in 1997. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

1997-10-09: Reporting owner Wegman Thomas; Form 5/A; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
1997-10-09: Reporting owner Wegman Thomas; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
1997-02-26: Reporting owner Wegman Thomas; Form 5/A; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
1997-02-26: Reporting owner Wegman Thomas; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).

All rows

Transaction date	Reporting owner	Form	Security	Transaction	Shares	Price	Filing
1997-10-09	Wegman Thomas Director, Officer (President)	5/A	Stock Option (Right to Buy) Derivative · Direct	A Grant, award or other acquisition pursuant to Rule 16b-3(d)	+1,500 1,500 owned after	$4.50 exercise price	2006-12-07
1997-10-09	Wegman Thomas Director, Officer (President)	5	Stock Option (Right to Buy) Derivative · Direct	A Grant, award or other acquisition pursuant to Rule 16b-3(d)	+1,500 1,500 owned after	$4.50 exercise price	2006-10-10
1997-02-26	Wegman Thomas Director, Officer (President)	5/A	Stock Option (Right to Buy) Derivative · Direct	A Grant, award or other acquisition pursuant to Rule 16b-3(d)	+1,000 1,000 owned after	$3.88 exercise price	2006-12-07
1997-02-26	Wegman Thomas Director, Officer (President)	5	Stock Option (Right to Buy) Derivative · Direct	A Grant, award or other acquisition pursuant to Rule 16b-3(d)	+1,000 1,000 owned after	$3.88 exercise price	2006-10-10